Trials / Completed
CompletedNCT01778101
Lansoprazole in Preterm Infants With Reflux
A Pilot Study - Lansoprazole in Preterm Infants With Gastroesophageal Reflux
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 4 Months
- Healthy volunteers
- Not accepted
Summary
This study is pilot study to evaluate safety and efficacy of lansoprazole in preterm infants with gastroesophageal reflux documented by 24hr pH impedance monitoring
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lansoprazole | lansoprazole 1mg/kg twice a day for 14days |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-05-01
- Completion
- 2013-06-01
- First posted
- 2013-01-29
- Last updated
- 2013-09-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01778101. Inclusion in this directory is not an endorsement.